Our extensive experience in health technology assessment (HTA) through providing strategic advice and guiding evidence generation to support submissions to UK HTA bodies, enables us to provide you with a tailored solution to reimbursement and patient access.
Case health economic
Development of the first HTA-ready cost-effectiveness model for epidermolysis bullosa (EB)